 |
Depósito mínimo $50 Promoción exclusiva |
Nuestra puntuación |
Comisión 0% |
Are you looking to buy NuVasive stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:NUVA! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about NuVasive stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company’s principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprises products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine to perform restorative and fusion procedures in a minimally disruptive fashion. The company’s biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty and gel. Its IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, it offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and Precice, a limb lengthening system. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.
Volumen medio
859,900 shs
TAPA DEL MERCADO
$3.00 billion
Bolsa
NASDAQ
¡Compre esta acción!
|
NOMBRE
|
TICKER
|
INDUSTRIA
|
SECTOR
|
VOLUMEN
|
COMPRE ESTA ACCIÓN AHORA
|
|---|---|---|---|---|---|
|
NASDAQ:NUVA
|
Instrumentos quirúrgicos y médicos
|
Médico
|
11,309 shs
|
Below is a quick guide on how to buy NASDAQ:NUVA stocks safe, fast and around the world in less than five minutes.
Paso 1: Abrir una cuenta en eToro – eToro is the best broker to buy NuVasive shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Paso 2: Suba su identificación - Según las regulaciones de KYC, eToro le pedirá que suba una copia de su pasaporte o licencia de conducir.
Paso 3: Depositar los fondos - Deposite algo de dinero en su recién creada cuenta de eToro. Puede elegir entre transferencia bancaria, monedero electrónico o tarjeta de débito/crédito o Paypal.
Paso 4: Buy NuVasive – Search for “”NASDAQ:NUVA”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought NuVasive stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
17 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for NuVasive in the last twelve months. There are currently 2 sell ratings, 8 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” NuVasive stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUVA, but not buy additional shares or sell existing shares.
Wall Street analysts have given NuVasive a “Hold” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but NuVasive wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
2 |  | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
3 |  | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:NUVA stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy NuVasive stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy NuVasive stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Debido a que eToro es una plataforma regulada, tendrá que completar el proceso KYC, esto es una práctica estándar y sólo toma un par de minutos. Tendrá que proporcionar un documento de identidad con fotografía (pasaporte, permiso de conducir) y un comprobante de domicilio (factura de servicios públicos, extracto bancario).
Una vez que se haya registrado y verificado su cuenta, deberá depositar fondos. eToro acepta tarjetas de crédito/débito, transferencias bancarias y también monederos electrónicos. Así que, sea cual sea su preferencia, habrá algo para usted.
Now that you’ve funded your eToro account, just type “NASDAQ:NUVA stocks" en la barra de búsqueda de la parte superior de la pantalla y pulse "comercio".
All that’s left is to buy some NASDAQ:NUVA stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:NUVA is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy NuVasive stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
NuVasive is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for NuVasive.
NuVasive, Inc. (NASDAQ:NUVA) posted its quarterly earnings data on Thursday, October, 29th. The medical device company reported $0.55 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.24 by $0.31. The medical device company earned $295.30 million during the quarter, compared to analysts’ expectations of $257.70 million. NuVasive had a negative net margin of 0.84% and a positive trailing twelve-month return on equity of 8.00%. NuVasive’s revenue was up 1.5% compared to the same quarter last year. During the same period last year, the company posted $0.59 EPS.
View NuVasive’s earnings history.
NuVasive’s stock was trading at $49.41 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NUVA stock has increased by 18.6% and is now trading at $58.61.
17 equities research analysts have issued 12-month price targets for NuVasive’s shares. Their forecasts range from $48.00 to $85.00. On average, they anticipate NuVasive’s share price to reach $62.00 in the next twelve months. This suggests a possible upside of 5.8% from the stock’s current price.
View analysts’ price targets for NuVasive or view top-rated stocks among Wall Street analysts.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:NUVA stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Más de 95% de los fondos de los clientes se mantienen fuera de línea, en almacenamiento en frío, lo que es crucial para cualquier corredor que gestione sus activos. Independientemente de lo segura que sea una plataforma, le recomendamos que utilice el sistema 2FA para añadir una capa adicional de seguridad a su cuenta.
eToro ofrece a los usuarios una serie de características para empezar a invertir lo antes posible. Tienen una característica relativamente única llamada copy trading, que le permite obtener un ingreso pasivo al imitar a operadores experimentados, esto le permite comenzar a obtener ganancias rápidamente, y le da una mejor comprensión de las estrategias utilizadas por los profesionales. Además, eToro permite a los usuarios invertir en carteras gestionadas, siendo una cartera gestionada una variedad de activos similares agrupados, lo que le permite diversificar su cuenta, reduciendo cualquier riesgo potencial. Para aquellos con experiencia previa en operaciones, puede invertir en mercados fuera de las acciones, ya que eToro permite a los usuarios operar con ETFs, materias primas, cripto e índices. Si ya invierte fuera del espacio bursátil, esto puede ser muy útil, ya que le permite gestionar todas sus inversiones en un solo lugar.
NuVasive’s management team includes the following people:
Mr. J. Christopher Barry, CEO & Director (Age 48, Pay $2.43M)
Mr. Nathaniel B. Sisitsky Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 47, Pay $686.56k)
Mr. Matthew K. Harbaugh, Exec. VP & CFO (Age 51)
Mr. Dale A. Wolf, Sr. VP of Global Operations (Age 41)
Mr. Johnson Lai, Chief Information Officer
Mr. Sean Freeman, Sr. VP of Strategy & Corp. Devel.
Mr. Lucas Vitale, Sr. VP & Chief HR Officer (Age 44)
Mr. Frank Middeke, Managing Director of DACH
Ms. Lisa Pecora, VP & Head of Global Commercial Fin.
Mr. Brent J. Boucher, Exec. VP of Global Commercial (Age 54)
59 employees have rated NuVasive CEO Chris Barry on Glassdoor.com. Chris Barry has an approval rating of 88% among NuVasive’s employees.
Los CFD son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento. 68% de las cuentas de inversores minoristas pierden dinero al operar con CFDs con este proveedor. Debe considerar si entiende cómo funcionan los CFD y si puede permitirse asumir el alto riesgo de perder su dinero.
Some companies that are related to NuVasive include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD) and Varian Medical Systems (VAR).
View all of NUVA’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other NuVasive investors own include BioMarin Pharmaceutical (BMRN), Incyte (INCY), Puma Biotechnology (PBYI), Intel (INTC), Alibaba Group (BABA), (MDVN) (MDVN), Micron Technology (MU), Bank of America (BAC), Gilead Sciences (GILD) and Applied Materials (AMAT).
NuVasive trades on the NASDAQ under the ticker symbol “NUVA.”
NuVasive’s stock is owned by a number of retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (2.09%), Fisher Asset Management LLC (1.84%), Scout Investments Inc. (0.98%), Fort Washington Investment Advisors Inc. OH (0.42%), Gamco Investors INC. ET AL (0.33%) and State of Wisconsin Investment Board (0.25%). Company insiders that own NuVasive stock include Gregory T Lucier, Matthew Link and Paul Mcclintock.
View institutional ownership trends for NuVasive.
1 | | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
NUVA stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Ziegler Capital Management LLC, SG Americas Securities LLC, State of Wisconsin Investment Board, Texas Permanent School Fund, Pacer Advisors Inc., New York State Teachers Retirement System, and California Public Employees Retirement System.
View insider buying and selling activity for NuVasive or view top insider-selling stocks.
NUVA stock was acquired by a variety of institutional investors in the last quarter, including Scout Investments Inc., Fort Washington Investment Advisors Inc. OH, Tower View Investment Management & Research LLC, Zurcher Kantonalbank Zurich Cantonalbank , Y Intercept Hong Kong Ltd, Gamco Investors INC. ET AL, Acorn Financial Advisory Services Inc. ADV, and IFP Advisors Inc.
View insider buying and selling activity for NuVasive or or view top insider-buying stocks.
Shares of NUVA can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisión de Interactive Brokers, Revisión de eToro, Revisión de DEGiro, Revisión de AvaTrade, Revisión de IG Markets, Revisión de los mercados IC, Revisión de CMC Markets, Revisión de Admiral Markets y muchos más. Lea una de las reseñas para saber todo sobre el corredor y comience a comprar acciones ahora.
One share of NUVA stock can currently be purchased for approximately $58.61.
NuVasive has a market capitalization of $3.01 billion and generates $1.17 billion in revenue each year. The medical device company earns $65.23 million in net income (profit) each year or $2.47 on an earnings per share basis.
NuVasive employs 2,800 workers across the globe.
En Reportlab.org queremos asegurarnos de que tenga toda la información más relevante sobre compra de acciones. Le ofrecemos las mejores guías sobre el mercado de valores con reseñas personales, información de fondo, reseñas de las plataformas, instrucciones y mucho más. ¿Quiere obtener otra información? Entonces consulte la Acciones OTC, Acciones del NASDAQ, Acciones de la Bolsa de Valores de Nueva York, Acciones LON, Acciones de la FRA, Acciones ETR, Reservas de la EPA, Acciones del TSX o Acciones Amex. Buscando información más detallada como 5g de existencias, acciones de biotecnología, acciones de oro y otra información de nuestro laboratorio de informes.
How can you buy NuVasive stock on the internet?
You can easily buy NuVasive stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Otra opción es utilizar un corredor regulado como Mercados IC o Corredores de bolsa interactivos. You can an account with these brokers and start buying or trading NASDAQ:NUVA stocks in a safe and complete environment to trade in.
Where to buy NuVasive stock?
You will first want to find a licensed broker that supports NASDAQ:NUVA stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:NUVA stocks in a safe and complete environment.
Is NASDAQ:NUVA stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:NUVA stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is NuVasive stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:NUVA is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in NuVasive stock.
How do you trade NuVasive stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for NuVasive stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:NUVA stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell NuVasive stock?
To sell your NASDAQ:NUVA stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best NuVasive stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:NUVA stock.
Stephen sabe mucho sobre productos financieros y, en particular, tiene una gran pasión por los mercados de valores y sus participantes. Esperamos que la información proporcionada le sirva de ayuda. ¿Hay algo que no está claro? Deje sus preguntas o comentarios al final de la página.
| Nuestra puntuación ★★★★★ | |
| Nuestra puntuación ★★★★★ | |
| Nuestra puntuación ★★★★★ |
Boletín de noticias
Noticias recientes
| |
Nuestra puntuación |
Comisión 0% |
Todos los valores de la EPA Más información Valores de la EPA ¿Qué es la Bolsa de París (EPA)? Ahora
Datos de acciones y criptografía en tiempo real
Notificaciones, consejos y noticias
Las mejores guías sobre acciones y criptografía
Reseñas sobre el corredor y la bolsa en línea
Reportlab Finanzas es una página web puramente informativa y en ningún caso implica un asesoramiento de inversión. Todas las inversiones conllevan riesgos y usted puede perder todas sus inversiones. No invierta dinero que no pueda permitirse perder.
Reportlab Finanzas
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos los derechos reservados.
